m+Medelevator.RU
← Поиск публикаций
Journal of cardiovascular echography · 2026

Three-dimensional Evaluation of Atrioventricular Valve Geometry in the Fetal Heart: Establishing Reference Standards and Clinical Validation.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Nogueira Tassyele Pamplona, Callado Gustavo Yanno, Bravo-Valenzuela Nathalie Jeanne, Araujo Júnior Edward

Аннотация

OBJECTIVE: To establish the reference values for the angle between the atrioventricular (AV) valve insertion levels in fetal hearts using three-dimensional ultrasound with Spatio-temporal Image Correlation (STIC) rendering and to validate these values in fetuses with confirmed congenital heart disease (CHD).

MATERIALS AND METHODS: A retrospective cross-sectional study was conducted using 59 STIC volumes from structurally normal fetuses between 20 and 33 + 6 weeks of gestation. The AV valve insertion angle was measured in the rendering mode of four-chamber view. A polynomial regression model was used to generate a reference curve and percentile table. A validation cohort of 26 fetuses with CHD was analyzed, and angle distributions were compared with the normative percentiles.

RESULTS: The insertion angle remained stable throughout gestation. Reference percentiles (5th, 10th, 50th, 90th, and 95th) were established by gestational week. Among fetuses with CHD, 46.2% had angles below the 5th percentile and 57.7% above the 95th percentile, with only 7.7% within the normal range. Specific CHD such as tetralogy of Fallot, transposition of the great arteries, and truncus arteriosus showed consistent deviations from normal values.

CONCLUSION: The AV valve insertion angle was a stable parameter throughout gestation and demonstrates significant deviation in fetuses with CHD. This measurement may serve as a useful screening tool for early prenatal identification of certain structural CHD.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты